MEDNAX (MD) Tops Q4 EPS by 1c, Revenues Beat; Offers Q1 EPS Mid-Point Guidance Below Consensus

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/2/2026

1. INTC
2. AMZN
3. COIN
4. RDDT
5. PINS
6. FSLR
7. DASH
8. SYK
9. MA
10. FND

Go back to MEDNAX (MD) Tops Q4 EPS by 1c, Revenues Beat; Offers Q1 EPS Mid-Point Guidance Below Consensus

MEDNAX Reports Fourth Quarter Results

February 20, 2020 6:00 AM EST

Announces Multi-State, Unilateral Termination by UnitedHealth Group

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)-- MEDNAX, Inc. (NYSE: MD), the national health solutions partner specializing in neonatology, anesthesiology, radiology, maternal-fetal medicine, and other pediatric services, today reported earnings from continuing operations of $0.40 per share for the three months ended December 31, 2019. On a non-GAAP basis, MEDNAX reported Adjusted EPS from continuing operations of $0.91.

For the 2019 fourth quarter, MEDNAX reported the following results from continuing operations:

Net revenue of $905 million; Net income of $33 million;... More